INVO Bioscience Revenue and Competitors
Estimated Revenue & Valuation
- INVO Bioscience's estimated annual revenue is currently $5.5M per year.
- INVO Bioscience's estimated revenue per employee is $251,000
Employee Data
- INVO Bioscience has 22 Employees.
- INVO Bioscience grew their employee count by -24% last year.
INVO Bioscience's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | VP, Brand & Strategic Communications | Reveal Email/Phone |
5 | COO/VP Business Development | Reveal Email/Phone |
6 | VP Quality and Regulatory Affairs | Reveal Email/Phone |
7 | Director Business Development | Reveal Email/Phone |
INVO Bioscience Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $26.1M | 104 | 0% | $63.5M | N/A |
#2 | $14.3M | 57 | -8% | N/A | N/A |
#3 | $33.1M | 132 | 6% | N/A | N/A |
#4 | $10.8M | 43 | 5% | N/A | N/A |
#5 | $488.3M | 1216 | 0% | N/A | N/A |
#6 | $14.3M | 57 | 10% | N/A | N/A |
#7 | $5M | 20 | -9% | N/A | N/A |
#8 | $95.6M | 381 | -1% | N/A | N/A |
#9 | $16.8M | 67 | 3% | N/A | N/A |
#10 | $57M | 227 | 13% | N/A | N/A |
What Is INVO Bioscience?
INVO Bioscience is a medical device company focused on creating simplified, lower cost treatments for patients diagnosed with infertility. Our INVOcell® Culture Device is a patented medical device used in the treatment of infertility that enables egg fertilization and early embryo development to take place in the woman’s body, in vivo. This revolutionary device promotes in vivo conception. It is an FDA cleared Intravaginal Culture (IVC) device that is a safe, effective and economical fertility treatment.
keywords:N/AN/A
Total Funding
22
Number of Employees
$5.5M
Revenue (est)
-24%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.5M | 22 | 0% | N/A |
#2 | $2.3M | 22 | 5% | N/A |
#3 | $4.2M | 22 | -19% | N/A |
#4 | $2.3M | 23 | -23% | N/A |
#5 | $2.3M | 23 | -55% | N/A |